SBL
RAIN

Sargent Bickham Lagudis’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Sargent Bickham Lagudis’s Portfolio RAIN Stock Details RAIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$14K Sell
1,749
-583
-25% -$3.66K ﹤0.01% 671
2022
Q3 		$11K Buy
+2,332
New +$14.6K ﹤0.01% 684

Other funds holding RAIN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sargent Bickham Lagudis's RAIN Position: Q4 2022 in Review

Sargent Bickham Lagudis reduced its Rain Oncology Inc. Common Stock (RAIN) stake by 25% in Q4 2022, selling an estimated $3.66K and leaving 1,749 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #671.

Sargent Bickham Lagudis first reported a position in RAIN in Q3 2022 and has held it in 2 quarters since. 46 funds tracked by Wall St. Rank hold RAIN as of Q4 2022.

  • Sargent Bickham Lagudis held 1,749 shares of Rain Oncology Inc. Common Stock worth $14K as of Q4 2022.
  • Sargent Bickham Lagudis sold 583 Rain Oncology Inc. Common Stock shares in Q4 2022, an estimated $3.66K.
  • Rain Oncology Inc. Common Stock made up ﹤0.01% of Sargent Bickham Lagudis's portfolio in Q4 2022, its #671 holding.
  • Sargent Bickham Lagudis first reported a position in Rain Oncology Inc. Common Stock in Q3 2022 and has held it in 2 quarters since.
  • 46 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q4 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q4 2022, filed 23 Jan 2023.